About
XII Medical is a clinical-stage health technology company based in Union City, California, founded in 2017. The company focuses on developing innovative neuromodulation therapies for obstructive sleep apnea (OSA), a serious sleep disorder caused by repeated airway blockages during sleep. Their core product platform aims to simplify treatment, expand patient access, and enhance clinical outcomes for those affected by OSA. Currently, XII Medical's technology is in the investigational phase and is not commercially available. The company has secured significant backing from a range of healthcare and venture capital investors, including Cleveland Clinic and Omega Funds. In August 2024, they raised $45 million in Series B financing to further their clinical and product development efforts. XII Medical is committed to providing less invasive and more accessible treatment options for OSA, targeting patients, healthcare providers, and clinical partners in the sleep medicine field.
Technologies
Keywords
Company Information
-
Employees 36
-
Founded 2017
-
Annual Revenue $8500000
-
Total Funding $90099995
Location
32980 Alvarado Niles Rd, Union City, California, United States, 94587